Reports

Industry Research Reports

Global Plasmid Purification Market Outlook, In‑Depth Analysis & Forecast to 2031

Global Plasmid Purification Market Outlook, In‑Depth Analysis & Forecast to 2031

Industry: Service & Software

Published Date: 2025-11-16

Pages: 139 Pages

Report ld: 5452865

application for samples

Request Sample

Custom reports

Customized Report

  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected
  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected

The global Plasmid Purification market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.

From a downstream perspective, Pharmaceutical and Biopharmaceutical Company accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).

Plasmid Purification leading manufacturers including Molecular Cloning Laboratories, Thermo Fisher Scientific, GENEWIZ, Inc., QIAGEN, New England Biolabs, Promega Corporation, Merck, BioVision, ZYMO RESEARCH, Bio-Rad, etc., dominate supply; the top five capture approximately % of global revenue, with Molecular Cloning Laboratories leading 2024 sales at US$ million.

Regional Outlook:

North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).

Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).

Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Plasmid Purification market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.

By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.

Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.

Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.

A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.

MARKET SEGMENTATION

By Company

  • Molecular Cloning Laboratories
  • Thermo Fisher Scientific
  • GENEWIZ, Inc.
  • QIAGEN
  • New England Biolabs
  • Promega Corporation
  • Merck
  • BioVision
  • ZYMO RESEARCH
  • Bio-Rad
  • ABP Biosciences
  • Lamda Biotech
  • Applied Biological Materials
  • PhyNexus
  • Takara Bio

Consumption by Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Segment by Type

  • Plasmid DNA
  • Bacterial Artificial Chromosome DNA

Segment by Application

  • Pharmaceutical and Biopharmaceutical Company
  • Research Laboratory
  • Hospital
  • Other

biaoTi CHAPTER OUTLINE

marn_i1

Chapter 1: Defines the Plasmid Purification study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.

marn_i1

Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts

marn_i1

Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.

marn_i1

Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks

marn_i1

Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.

marn_i1

Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.

marn_i1

Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.

marn_i1

Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.

marn_i1

Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.

marn_i1

Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles

marn_i1

Chapter 11: Profiles players in depth—details product specs, revenue, margins; top-tier players 2024 sales breakdowns by product type, by Application, by region SWOT analysis, and recent strategic developments.

marn_i1

Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.

marn_i1

Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.

marn_i1

Chapter 14: Actionable conclusions and strategic recommendations.

WHY THIS REPORT

Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:

Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:

Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).

Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.

Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).

Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).

Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region
Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

den_ic6
Product mix optimization based on local practices
Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

den_ic6
Competitor tactics in fragmented vs. consolidated markets
Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

den_ic6
Full Research Coverage
Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

den_ic6
19 Years Industry Expertise
19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

den_ic6
24/7 Fast Report Delivery
24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

den_ic6
Localized Strategic Analysis
Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

den_ic6
den_biaoTiZhungShi

TABLE OF CONTENTS

muLu

1 Study Coverage

1.1 Introduction to Plasmid Purification: Definition, Properties, and Key Attributes

1.2 Market Segmentation by Type

1.2.1 Global Plasmid Purification Market Size by Type, 2020 VS 2024 VS 2031

1.2.2 Plasmid DNA

1.2.3 Bacterial Artificial Chromosome DNA

1.3 Market Segmentation by Application

1.3.1 Global Plasmid Purification Market Size by Application, 2020 VS 2024 VS 2031

1.3.2 Pharmaceutical and Biopharmaceutical Company

1.3.3 Research Laboratory

1.3.4 Hospital

1.3.5 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

muLu

2 Executive Summary

2.1 Global Plasmid Purification Revenue Estimates and Forecasts 2020-2031

2.2 Global Plasmid Purification Revenue by Region

2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031

2.2.2 Historical and Forecasted Revenue by Region (2020-2031)

2.2.3 Global Revenue Market Share by Region (2020-2031)

2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends

muLu

3 Competition by Players

3.1 Global Plasmid Purification Player Revenue Rankings and Profitability

3.1.1 Global Revenue (Value) by Players (2020-2025)

3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)

3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)

3.1.4 Gross Margin by Top Player (2020 VS 2024)

3.2 Global Plasmid Purification Companies Headquarters and Service Footprint

3.3 Main Product Type Market Size by Players

3.3.1 Plasmid DNA Market Size by Players

3.3.2 Bacterial Artificial Chromosome DNA Market Size by Players

3.4 Global Plasmid Purification Market Concentration and Dynamics

3.4.1 Global Market Concentration (CR5 and HHI)

3.4.2 Entrant/Exit Impact Analysis

3.4.3 Strategic Moves: M&A, Expansion, R&D Investment

muLu

4 Global Product Segmentation Analysis

4.1 Global Plasmid Purification Revenue Trends by Type

4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)

4.1.2 Global Revenue Market Share by Type (2020-2031)

4.2 Key Product Attributes and Differentiation

4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk

4.3.1 High-Growth Niches and Adoption Drivers

4.3.2 Profitability Hotspots and Cost Drivers

4.3.3 Substitution Threats

muLu

5 Global Downstream Application Analysis

5.1 Global Plasmid Purification Revenue by Application

5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)

5.1.2 Revenue Market Share by Application (2020-2031)

5.1.3 High-Growth Application Identification

5.1.4 Emerging Application Case Studies

5.2 Downstream Customer Analysis

5.2.1 Top Customers by Region

5.2.2 Top Customers by Application

muLu

6 North America

6.1 North America Market Size (2020-2031)

6.2 North America Key Players Revenue in 2024

6.3 North America Plasmid Purification Market Size by Type (2020-2031)

6.4 North America Plasmid Purification Market Size by Application (2020-2031)

6.5 North America Growth Accelerators and Market Barriers

6.6 North America Plasmid Purification Market Size by Country

6.6.1 North America Revenue Trends by Country

6.6.2 US

6.6.3 Canada

6.6.4 Mexico

muLu

7 Europe

7.1 Europe Market Size (2020-2031)

7.2 Europe Key Players Revenue in 2024

7.3 Europe Plasmid Purification Market Size by Type (2020-2031)

7.4 Europe Plasmid Purification Market Size by Application (2020-2031)

7.5 Europe Growth Accelerators and Market Barriers

7.6 Europe Plasmid Purification Market Size by Country

7.6.1 Europe Revenue Trends by Country

7.6.2 Germany

7.6.3 France

7.6.4 U.K.

7.6.5 Italy

7.6.6 Russia

muLu

8 Asia-Pacific

8.1 Asia-Pacific Market Size (2020-2031)

8.2 Asia-Pacific Key Players Revenue in 2024

8.3 Asia-Pacific Plasmid Purification Market Size by Type (2020-2031)

8.4 Asia-Pacific Plasmid Purification Market Size by Application (2020-2031)

8.5 Asia-Pacific Growth Accelerators and Market Barriers

8.6 Asia-Pacific Plasmid Purification Market Size by Region

8.6.1 Asia-Pacific Revenue Trends by Region

8.7 China

8.8 Japan

8.9 South Korea

8.10 Australia

8.11 India

8.12 Southeast Asia

8.12.1 Indonesia

8.12.2 Vietnam

8.12.3 Malaysia

8.12.4 Philippines

8.12.5 Singapore

muLu

9 Central and South America

9.1 Central and South America Market Size (2020-2031)

9.2 Central and South America Key Players Revenue in 2024

9.3 Central and South America Plasmid Purification Market Size by Type (2020-2031)

9.4 Central and South America Plasmid Purification Market Size by Application (2020-2031)

9.5 Central and South America Investment Opportunities and Key Challenges

9.6 Central and South America Plasmid Purification Market Size by Country

9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)

9.6.2 Brazil

9.6.3 Argentina

muLu

10 Middle East and Africa

10.1 Middle East and Africa Market Size (2020-2031)

10.2 Middle East and Africa Key Players Revenue in 2024

10.3 Middle East and Africa Plasmid Purification Market Size by Type (2020-2031)

10.4 Middle East and Africa Plasmid Purification Market Size by Application (2020-2031)

10.5 Middle East and Africa Investment Opportunities and Key Challenges

10.6 Middle East and Africa Plasmid Purification Market Size by Country

10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)

10.6.2 GCC Countries

10.6.3 Israel

10.6.4 Egypt

10.6.5 South Africa

muLu

11 Corporate Profile

11.1 Molecular Cloning Laboratories

11.1.1 Molecular Cloning Laboratories Corporation Information

11.1.2 Molecular Cloning Laboratories Business Overview

11.1.3 Molecular Cloning Laboratories Plasmid Purification Product Features and Attributes

11.1.4 Molecular Cloning Laboratories Plasmid Purification Revenue and Gross Margin (2020-2025)

11.1.5 Molecular Cloning Laboratories Plasmid Purification Revenue by Product in 2024

11.1.6 Molecular Cloning Laboratories Plasmid Purification Revenue by Application in 2024

11.1.7 Molecular Cloning Laboratories Plasmid Purification Revenue by Geographic Area in 2024

11.1.8 Molecular Cloning Laboratories Plasmid Purification SWOT Analysis

11.1.9 Molecular Cloning Laboratories Recent Developments

11.2 Thermo Fisher Scientific

11.2.1 Thermo Fisher Scientific Corporation Information

11.2.2 Thermo Fisher Scientific Business Overview

11.2.3 Thermo Fisher Scientific Plasmid Purification Product Features and Attributes

11.2.4 Thermo Fisher Scientific Plasmid Purification Revenue and Gross Margin (2020-2025)

11.2.5 Thermo Fisher Scientific Plasmid Purification Revenue by Product in 2024

11.2.6 Thermo Fisher Scientific Plasmid Purification Revenue by Application in 2024

11.2.7 Thermo Fisher Scientific Plasmid Purification Revenue by Geographic Area in 2024

11.2.8 Thermo Fisher Scientific Plasmid Purification SWOT Analysis

11.2.9 Thermo Fisher Scientific Recent Developments

11.3 GENEWIZ, Inc.

11.3.1 GENEWIZ, Inc. Corporation Information

11.3.2 GENEWIZ, Inc. Business Overview

11.3.3 GENEWIZ, Inc. Plasmid Purification Product Features and Attributes

11.3.4 GENEWIZ, Inc. Plasmid Purification Revenue and Gross Margin (2020-2025)

11.3.5 GENEWIZ, Inc. Plasmid Purification Revenue by Product in 2024

11.3.6 GENEWIZ, Inc. Plasmid Purification Revenue by Application in 2024

11.3.7 GENEWIZ, Inc. Plasmid Purification Revenue by Geographic Area in 2024

11.3.8 GENEWIZ, Inc. Plasmid Purification SWOT Analysis

11.3.9 GENEWIZ, Inc. Recent Developments

11.4 QIAGEN

11.4.1 QIAGEN Corporation Information

11.4.2 QIAGEN Business Overview

11.4.3 QIAGEN Plasmid Purification Product Features and Attributes

11.4.4 QIAGEN Plasmid Purification Revenue and Gross Margin (2020-2025)

11.4.5 QIAGEN Plasmid Purification Revenue by Product in 2024

11.4.6 QIAGEN Plasmid Purification Revenue by Application in 2024

11.4.7 QIAGEN Plasmid Purification Revenue by Geographic Area in 2024

11.4.8 QIAGEN Plasmid Purification SWOT Analysis

11.4.9 QIAGEN Recent Developments

11.5 New England Biolabs

11.5.1 New England Biolabs Corporation Information

11.5.2 New England Biolabs Business Overview

11.5.3 New England Biolabs Plasmid Purification Product Features and Attributes

11.5.4 New England Biolabs Plasmid Purification Revenue and Gross Margin (2020-2025)

11.5.5 New England Biolabs Plasmid Purification Revenue by Product in 2024

11.5.6 New England Biolabs Plasmid Purification Revenue by Application in 2024

11.5.7 New England Biolabs Plasmid Purification Revenue by Geographic Area in 2024

11.5.8 New England Biolabs Plasmid Purification SWOT Analysis

11.5.9 New England Biolabs Recent Developments

11.6 Promega Corporation

11.6.1 Promega Corporation Corporation Information

11.6.2 Promega Corporation Business Overview

11.6.3 Promega Corporation Plasmid Purification Product Features and Attributes

11.6.4 Promega Corporation Plasmid Purification Revenue and Gross Margin (2020-2025)

11.6.5 Promega Corporation Recent Developments

11.7 Merck

11.7.1 Merck Corporation Information

11.7.2 Merck Business Overview

11.7.3 Merck Plasmid Purification Product Features and Attributes

11.7.4 Merck Plasmid Purification Revenue and Gross Margin (2020-2025)

11.7.5 Merck Recent Developments

11.8 BioVision

11.8.1 BioVision Corporation Information

11.8.2 BioVision Business Overview

11.8.3 BioVision Plasmid Purification Product Features and Attributes

11.8.4 BioVision Plasmid Purification Revenue and Gross Margin (2020-2025)

11.8.5 BioVision Recent Developments

11.9 ZYMO RESEARCH

11.9.1 ZYMO RESEARCH Corporation Information

11.9.2 ZYMO RESEARCH Business Overview

11.9.3 ZYMO RESEARCH Plasmid Purification Product Features and Attributes

11.9.4 ZYMO RESEARCH Plasmid Purification Revenue and Gross Margin (2020-2025)

11.9.5 ZYMO RESEARCH Recent Developments

11.10 Bio-Rad

11.10.1 Bio-Rad Corporation Information

11.10.2 Bio-Rad Business Overview

11.10.3 Bio-Rad Plasmid Purification Product Features and Attributes

11.10.4 Bio-Rad Plasmid Purification Revenue and Gross Margin (2020-2025)

11.10.5 Company Ten Recent Developments

11.11 ABP Biosciences

11.11.1 ABP Biosciences Corporation Information

11.11.2 ABP Biosciences Business Overview

11.11.3 ABP Biosciences Plasmid Purification Product Features and Attributes

11.11.4 ABP Biosciences Plasmid Purification Revenue and Gross Margin (2020-2025)

11.11.5 ABP Biosciences Recent Developments

11.12 Lamda Biotech

11.12.1 Lamda Biotech Corporation Information

11.12.2 Lamda Biotech Business Overview

11.12.3 Lamda Biotech Plasmid Purification Product Features and Attributes

11.12.4 Lamda Biotech Plasmid Purification Revenue and Gross Margin (2020-2025)

11.12.5 Lamda Biotech Recent Developments

11.13 Applied Biological Materials

11.13.1 Applied Biological Materials Corporation Information

11.13.2 Applied Biological Materials Business Overview

11.13.3 Applied Biological Materials Plasmid Purification Product Features and Attributes

11.13.4 Applied Biological Materials Plasmid Purification Revenue and Gross Margin (2020-2025)

11.13.5 Applied Biological Materials Recent Developments

11.14 PhyNexus

11.14.1 PhyNexus Corporation Information

11.14.2 PhyNexus Business Overview

11.14.3 PhyNexus Plasmid Purification Product Features and Attributes

11.14.4 PhyNexus Plasmid Purification Revenue and Gross Margin (2020-2025)

11.14.5 PhyNexus Recent Developments

11.15 Takara Bio

11.15.1 Takara Bio Corporation Information

11.15.2 Takara Bio Business Overview

11.15.3 Takara Bio Plasmid Purification Product Features and Attributes

11.15.4 Takara Bio Plasmid Purification Revenue and Gross Margin (2020-2025)

11.15.5 Takara Bio Recent Developments

muLu

12 Plasmid PurificationIndustry Chain Analysis

12.1 Plasmid Purification Industry Chain

12.2 Upstream Analysis

12.2.1 Upstream Key Suppliers

12.3 Middlestream Analysis

12.4 Downstream Sales Model and Distribution Networks

12.4.1 Sales Channels

12.4.2 Distributors

muLu

13 Plasmid Purification Market Dynamics

13.1 Industry Trends and Evolution

13.2 Market Growth Drivers and Emerging Opportunities

13.3 Market Challenges, Risks, and Restraints

muLu

14 Key Findings in the Global Plasmid Purification Study

muLu

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.1.1 Research Programs/Design

15.1.1.2 Market Size Estimation

15.1.1.3 Market Breakdown and Data Triangulation

15.1.2 Data Source

15.1.2.1 Secondary Sources

15.1.2.2 Primary Sources

15.2 Author Details

den_biaoTiZhungShi

TABLE OF FIGURES

muLu

List of Tables

Table 1. Global Plasmid Purification Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Plasmid Purification Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Plasmid Purification Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Plasmid Purification Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Plasmid Purification Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global Plasmid Purification Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global Plasmid Purification Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global Plasmid Purification by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasmid Purification as of 2024)
Table 11. Global Plasmid Purification Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global Plasmid Purification Companies Headquarters
Table 13. Global Plasmid Purification Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global Plasmid Purification Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global Plasmid Purification Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global Plasmid Purification Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global Plasmid Purification Revenue by Application (2026-2031) & (US$ Million)
Table 21. Plasmid Purification High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America Plasmid Purification Growth Accelerators and Market Barriers
Table 25. North America Plasmid Purification Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe Plasmid Purification Growth Accelerators and Market Barriers
Table 27. Europe Plasmid Purification Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific Plasmid Purification Growth Accelerators and Market Barriers
Table 29. Asia-Pacific Plasmid Purification Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America Plasmid Purification Investment Opportunities and Key Challenges
Table 31. Central and South America Plasmid Purification Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa Plasmid Purification Investment Opportunities and Key Challenges
Table 33. Middle East and Africa Plasmid Purification Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. Molecular Cloning Laboratories Corporation Information
Table 35. Molecular Cloning Laboratories Description and Major Businesses
Table 36. Molecular Cloning Laboratories Product Features and Attributes
Table 37. Molecular Cloning Laboratories Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. Molecular Cloning Laboratories Revenue Proportion by Product in 2024
Table 39. Molecular Cloning Laboratories Revenue Proportion by Application in 2024
Table 40. Molecular Cloning Laboratories Revenue Proportion by Geographic Area in 2024
Table 41. Molecular Cloning Laboratories Plasmid Purification SWOT Analysis
Table 42. Molecular Cloning Laboratories Recent Developments
Table 43. Thermo Fisher Scientific Corporation Information
Table 44. Thermo Fisher Scientific Description and Major Businesses
Table 45. Thermo Fisher Scientific Product Features and Attributes
Table 46. Thermo Fisher Scientific Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Thermo Fisher Scientific Revenue Proportion by Product in 2024
Table 48. Thermo Fisher Scientific Revenue Proportion by Application in 2024
Table 49. Thermo Fisher Scientific Revenue Proportion by Geographic Area in 2024
Table 50. Thermo Fisher Scientific Plasmid Purification SWOT Analysis
Table 51. Thermo Fisher Scientific Recent Developments
Table 52. GENEWIZ, Inc. Corporation Information
Table 53. GENEWIZ, Inc. Description and Major Businesses
Table 54. GENEWIZ, Inc. Product Features and Attributes
Table 55. GENEWIZ, Inc. Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. GENEWIZ, Inc. Revenue Proportion by Product in 2024
Table 57. GENEWIZ, Inc. Revenue Proportion by Application in 2024
Table 58. GENEWIZ, Inc. Revenue Proportion by Geographic Area in 2024
Table 59. GENEWIZ, Inc. Plasmid Purification SWOT Analysis
Table 60. GENEWIZ, Inc. Recent Developments
Table 61. QIAGEN Corporation Information
Table 62. QIAGEN Description and Major Businesses
Table 63. QIAGEN Product Features and Attributes
Table 64. QIAGEN Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. QIAGEN Revenue Proportion by Product in 2024
Table 66. QIAGEN Revenue Proportion by Application in 2024
Table 67. QIAGEN Revenue Proportion by Geographic Area in 2024
Table 68. QIAGEN Plasmid Purification SWOT Analysis
Table 69. QIAGEN Recent Developments
Table 70. New England Biolabs Corporation Information
Table 71. New England Biolabs Description and Major Businesses
Table 72. New England Biolabs Product Features and Attributes
Table 73. New England Biolabs Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. New England Biolabs Revenue Proportion by Product in 2024
Table 75. New England Biolabs Revenue Proportion by Application in 2024
Table 76. New England Biolabs Revenue Proportion by Geographic Area in 2024
Table 77. New England Biolabs Plasmid Purification SWOT Analysis
Table 78. New England Biolabs Recent Developments
Table 79. Promega Corporation Corporation Information
Table 80. Promega Corporation Description and Major Businesses
Table 81. Promega Corporation Product Features and Attributes
Table 82. Promega Corporation Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. Promega Corporation Recent Developments
Table 84. Merck Corporation Information
Table 85. Merck Description and Major Businesses
Table 86. Merck Product Features and Attributes
Table 87. Merck Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. Merck Recent Developments
Table 89. BioVision Corporation Information
Table 90. BioVision Description and Major Businesses
Table 91. BioVision Product Features and Attributes
Table 92. BioVision Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. BioVision Recent Developments
Table 94. ZYMO RESEARCH Corporation Information
Table 95. ZYMO RESEARCH Description and Major Businesses
Table 96. ZYMO RESEARCH Product Features and Attributes
Table 97. ZYMO RESEARCH Revenue (US$ Million) and Gross Margin (2020-2025)
Table 98. ZYMO RESEARCH Recent Developments
Table 99. Bio-Rad Corporation Information
Table 100. Bio-Rad Description and Major Businesses
Table 101. Bio-Rad Product Features and Attributes
Table 102. Bio-Rad Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. Bio-Rad Recent Developments
Table 104. ABP Biosciences Corporation Information
Table 105. ABP Biosciences Description and Major Businesses
Table 106. ABP Biosciences Product Features and Attributes
Table 107. ABP Biosciences Revenue (US$ Million) and Gross Margin (2020-2025)
Table 108. ABP Biosciences Recent Developments
Table 109. Lamda Biotech Corporation Information
Table 110. Lamda Biotech Description and Major Businesses
Table 111. Lamda Biotech Product Features and Attributes
Table 112. Lamda Biotech Revenue (US$ Million) and Gross Margin (2020-2025)
Table 113. Lamda Biotech Recent Developments
Table 114. Applied Biological Materials Corporation Information
Table 115. Applied Biological Materials Description and Major Businesses
Table 116. Applied Biological Materials Product Features and Attributes
Table 117. Applied Biological Materials Revenue (US$ Million) and Gross Margin (2020-2025)
Table 118. Applied Biological Materials Recent Developments
Table 119. PhyNexus Corporation Information
Table 120. PhyNexus Description and Major Businesses
Table 121. PhyNexus Product Features and Attributes
Table 122. PhyNexus Revenue (US$ Million) and Gross Margin (2020-2025)
Table 123. PhyNexus Recent Developments
Table 124. Takara Bio Corporation Information
Table 125. Takara Bio Description and Major Businesses
Table 126. Takara Bio Product Features and Attributes
Table 127. Takara Bio Revenue (US$ Million) and Gross Margin (2020-2025)
Table 128. Takara Bio Recent Developments
Table 129. Raw Materials Key Suppliers
Table 130. Distributors List
Table 131. Market Trends and Market Evolution
Table 132. Market Drivers and Opportunities
Table 133. Market Challenges, Risks, and Restraints
Table 134. Research Programs/Design for This Report
Table 135. Key Data Information from Secondary Sources
Table 136. Key Data Information from Primary Sources
muLu

List of Figures

Figure 1. Plasmid Purification Product Picture
Figure 2. Global Plasmid Purification Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Plasmid DNA Product Picture
Figure 4. Bacterial Artificial Chromosome DNA Product Picture
Figure 5. Global Plasmid Purification Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Pharmaceutical and Biopharmaceutical Company
Figure 7. Research Laboratory
Figure 8. Hospital
Figure 9. Other
Figure 10. Plasmid Purification Report Years Considered
Figure 11. Global Plasmid Purification Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Plasmid Purification Revenue (2020-2031) & (US$ Million)
Figure 13. Global Plasmid Purification Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 14. Global Plasmid Purification Revenue Market Share by Region (2020-2031)
Figure 15. Global Plasmid Purification Revenue Market Share Ranking (2024)
Figure 16. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 17. Plasmid DNA Revenue Market Share by Player in 2024
Figure 18. Bacterial Artificial Chromosome DNA Revenue Market Share by Player in 2024
Figure 19. Global Plasmid Purification Revenue Market Share by Type (2020-2031)
Figure 20. Global Plasmid Purification Revenue Market Share by Application (2020-2031)
Figure 21. North America Plasmid Purification Revenue YoY (2020-2031) & (US$ Million)
Figure 22. North America Top 5 Players Plasmid Purification Revenue (US$ Million) in 2024
Figure 23. North America Plasmid Purification Revenue (US$ Million) by Type (2020 - 2031)
Figure 24. North America Plasmid Purification Revenue (US$ Million) by Application (2020-2031)
Figure 25. US Plasmid Purification Revenue (2020-2031) & (US$ Million)
Figure 26. Canada Plasmid Purification Revenue (2020-2031) & (US$ Million)
Figure 27. Mexico Plasmid Purification Revenue (2020-2031) & (US$ Million)
Figure 28. Europe Plasmid Purification Revenue YoY (2020-2031) & (US$ Million)
Figure 29. Europe Top 5 Players Plasmid Purification Revenue (US$ Million) in 2024
Figure 30. Europe Plasmid Purification Revenue (US$ Million) by Type (2020-2031)
Figure 31. Europe Plasmid Purification Revenue (US$ Million) by Application (2020-2031)
Figure 32. Germany Plasmid Purification Revenue (2020-2031) & (US$ Million)
Figure 33. France Plasmid Purification Revenue (2020-2031) & (US$ Million)
Figure 34. U.K. Plasmid Purification Revenue (2020-2031) & (US$ Million)
Figure 35. Italy Plasmid Purification Revenue (2020-2031) & (US$ Million)
Figure 36. Russia Plasmid Purification Revenue (2020-2031) & (US$ Million)
Figure 37. Asia-Pacific Plasmid Purification Revenue YoY (2020-2031) & (US$ Million)
Figure 38. Asia-Pacific Top 8 Players Plasmid Purification Revenue (US$ Million) in 2024
Figure 39. Asia-Pacific Plasmid Purification Revenue (US$ Million) by Type (2020-2031)
Figure 40. Asia-Pacific Plasmid Purification Revenue (US$ Million) by Application (2020-2031)
Figure 41. Indonesia Plasmid Purification Revenue (2020-2031) & (US$ Million)
Figure 42. Japan Plasmid Purification Revenue (2020-2031) & (US$ Million)
Figure 43. South Korea Plasmid Purification Revenue (2020-2031) & (US$ Million)
Figure 44. Australia Plasmid Purification Revenue (2020-2031) & (US$ Million)
Figure 45. India Plasmid Purification Revenue (2020-2031) & (US$ Million)
Figure 46. Indonesia Plasmid Purification Revenue (2020-2031) & (US$ Million)
Figure 47. Vietnam Plasmid Purification Revenue (2020-2031) & (US$ Million)
Figure 48. Malaysia Plasmid Purification Revenue (2020-2031) & (US$ Million)
Figure 49. Philippines Plasmid Purification Revenue (2020-2031) & (US$ Million)
Figure 50. Singapore Plasmid Purification Revenue (2020-2031) & (US$ Million)
Figure 51. Central and South America Plasmid Purification Revenue YoY (2020-2031) & (US$ Million)
Figure 52. Central and South America Top 5 Players Plasmid Purification Revenue (US$ Million) in 2024
Figure 53. Central and South America Plasmid Purification Revenue (US$ Million) by Type (2020-2031)
Figure 54. Central and South America Plasmid Purification Revenue (US$ Million) by Application (2020-2031)
Figure 55. Brazil Plasmid Purification Revenue (2020-2025) & (US$ Million)
Figure 56. Argentina Plasmid Purification Revenue (2020-2025) & (US$ Million)
Figure 57. Middle East and Africa Plasmid Purification Revenue YoY (2020-2031) & (US$ Million)
Figure 58. Middle East and Africa Top 5 Players Plasmid Purification Revenue (US$ Million) in 2024
Figure 59. South America Plasmid Purification Revenue (US$ Million) by Type (2020-2031)
Figure 60. Middle East and Africa Plasmid Purification Revenue (US$ Million) by Application (2020-2031)
Figure 61. GCC Countries Plasmid Purification Revenue (2020-2025) & (US$ Million)
Figure 62. Israel Plasmid Purification Revenue (2020-2025) & (US$ Million)
Figure 63. Egypt Plasmid Purification Revenue (2020-2025) & (US$ Million)
Figure 64. South Africa Plasmid Purification Revenue (2020-2025) & (US$ Million)
Figure 65. Plasmid Purification Industry Chain Mapping
Figure 66. Channels of Distribution (Direct Vs Distribution)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
den_biaoTiZhungShi

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Plasmid Purification market?zhanKai
The top companies in the global Plasmid Purification market are Molecular Cloning Laboratories、Thermo Fisher Scientific、GENEWIZ, Inc..
den_biaoTiZhungShi

Related Reports

Global Plasmid Purification Market Outlook, In‑Depth Analysis & Forecast to 2031

Industry: Service & Software

Published Date: 2025-11-16

Pages: 139 Pages

Report ld: 5452865

CHOOSE LICENSE TYPE
tip

USD 4900.00

tip

USD 7350.00

tip

USD 9800.00

Add to Cart

Add to Cart

Buy Now

Buy Now

HAVE A QUESTION?
SIMON LEE

English,Chinese

Offline

HITESH

English, Hindi

Offline

TANG XIN

Japanese,English

Online

SUNG-BIN YOON

SUNG-BIN YOON

+82-2883 1278

Korean, English

Online

YUJIE TIAN

Chinese, English

Online

DAMON

Chinese, English

Online

General Email:

REPORT COVERAGE

den_ic8

DESCRIPTION

zhankai
den_ic7

OVERVIEW

den_ic7

MARKET SEGMENTATION

den_ic7

CHAPTER OUTLINE

den_ic7

WHY THIS REPORT

den_ic7

QYRESEARCH'S STRENGTHS

den_ic8

TABLE OF CONTENTS

den_ic8

TABLE OF FIGURES

den_ic8

RLEATED REPORTS

INTEREST IN THIS REPORT?

yangBenGet A Free Sample

baoJia Request For Quotation

OR

NEED A CUSTOMIZED REPORT?

DingZhiCustomized Report

biaoTi

WORLD WIDE OFFICE

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

Add to Cart

Add to Cart

Buy Now

Buy Now